AR048029A1 - EFFECTIVE ORAL DOSAGE FORMS OF OPIACEES AND METHODS OF ADMINISTRATION OF OPIACEANS - Google Patents

EFFECTIVE ORAL DOSAGE FORMS OF OPIACEES AND METHODS OF ADMINISTRATION OF OPIACEANS

Info

Publication number
AR048029A1
AR048029A1 ARP050100913A AR048029A1 AR 048029 A1 AR048029 A1 AR 048029A1 AR P050100913 A ARP050100913 A AR P050100913A AR 048029 A1 AR048029 A1 AR 048029A1
Authority
AR
Argentina
Prior art keywords
dosage forms
administration
methods
opiacees
opiaceans
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Cima Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/026,759 external-priority patent/US7862833B2/en
Application filed by Cima Labs Inc filed Critical Cima Labs Inc
Publication of AR048029A1 publication Critical patent/AR048029A1/en

Links

Classifications

    • Y02W90/11—

Abstract

Formas de dosificacion que contienen opiáceos y métodos de uso de los mismos. Estas formas de dosificacion incluyen substancialmente menos opiáceos por peso que las formulaciones orales conocidas. Estas formas de dosificacion están destinadas a la administracion oral a través de la mucosa oral. Reivindicacion 1: Una forma de dosificacion caracterizada porque comprende entre aproximadamente 20 y aproximadamente 200,000 microgramos de un opiáceo, entre aproximadamente 0,5 y aproximadamente 25% p/p de una sustancia para ajustar el pH apropiada para dicho opiáceo, entre aproximadamente 5 y aproximadamente 85% p/p de un material efervescente, y un almidon glicolato, donde dicha forma de dosificacion está disenada para la administracion de dicho opiáceo a través de la mucosa oral por vía oral, gingival o sublingual.Dosage forms containing opiates and methods of use thereof. These dosage forms include substantially less opioids by weight than known oral formulations. These dosage forms are intended for oral administration through the oral mucosa. Claim 1: A dosage form characterized in that it comprises between about 20 and about 200,000 micrograms of an opioid, between about 0.5 and about 25% w / w of a substance to adjust the appropriate pH for said opioid, between about 5 and about 85% w / w of an effervescent material, and a glycolate starch, where said dosage form is designed for the administration of said opioid through the oral mucosa by oral, gingival or sublingual route.

ARP050100913 2004-10-04 2005-03-09 EFFECTIVE ORAL DOSAGE FORMS OF OPIACEES AND METHODS OF ADMINISTRATION OF OPIACEANS AR048029A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61566504P 2004-10-04 2004-10-04
US61578504P 2004-10-04 2004-10-04
US11/026,759 US7862833B2 (en) 2003-12-31 2004-12-30 Effervescent oral opiate dosage forms and methods of administering opiates

Publications (1)

Publication Number Publication Date
AR048029A1 true AR048029A1 (en) 2006-03-22

Family

ID=36607230

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050100913 AR048029A1 (en) 2004-10-04 2005-03-09 EFFECTIVE ORAL DOSAGE FORMS OF OPIACEES AND METHODS OF ADMINISTRATION OF OPIACEANS

Country Status (1)

Country Link
AR (1) AR048029A1 (en)

Similar Documents

Publication Publication Date Title
NO20063429L (en) Coarse oral opiate dosage form
BRPI0418228A (en) dosage form, and methods of treating pain and incident cancer pain episodes, and preparing a tablet for oral, gingival or sublingual administration of fentanyl
SV2006002473A (en) ORTORROMBICAL CRYSTAL FORM OF ASENAPINE MALEATE AND ITS USE IN THE TREATMENT OF MENTAL DISORDERS REF. 2005,893 (806,671)
NO993520D0 (en) Dosage forms and methods for improving erectile dysfunction
WO2005065317A3 (en) Effervescent oral fentanyl dosage form
BR0208382A (en) Nicotine-containing oral dosage form
BR0314271A (en) Solid oral dosage form useful for oral transmucosal administration, and, methods of reducing cravings for nicotine, and, tobacco use
AR054806A1 (en) FORMULATIONS OF CONJUGATED STROGENS AND BAZEDOXIFEN
AR051397A1 (en) PHARMACEUTICAL COMPOSITION
ATE554746T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORIN
PA8625001A1 (en) FILM COMPOSITIONS
PA8484301A1 (en) PHARMACEUTICAL FORMULATIONS OF CONTROLLED LIBERATION
AR065581A1 (en) IMPROVEMENTS IN MEDICINAL COMPOSITIONS OR RELATED TO THE SAME
ATE499939T1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLIBANSERIN POLYMORPHO A
AR070593A1 (en) EFFECTIVE COMPOSITIONS
AR036937A1 (en) CHEATABLE TABLET CONTAINING LISINA
PE20090625A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING BUPRENORPHINE AND NALMEFENE
BRPI0410044B8 (en) dosage form containing pantoprazole as active ingredient
AR098347A2 (en) USE OF FENTANIL ORAL EFERVESCENT DOSAGE
AR048029A1 (en) EFFECTIVE ORAL DOSAGE FORMS OF OPIACEES AND METHODS OF ADMINISTRATION OF OPIACEANS
HUP0400495A2 (en) Oral mucosal dosage forms of apomorphine, suitable for the administration via oral mucosal tissue
AR047999A1 (en) EFFECTIVE ORAL DOSAGE FORM OF FENTANIL AND METHODS OF ADMINISTRATION OF FENTANIL
AR048000A1 (en) SUBSTANTIALLY LINEAR EFERVESCENT ORAL DOSAGE FORM OF FENTANIL AND METHODS OF ADMINISTRATION
WO2008046041A3 (en) Dissolving strip for oral mucosa as a systemic drug delivery route
CO5271688A1 (en) USE OF APOLIPROTEIN B AND / OR SECRETION INHIBITOR OF MICROSMAL TRIGLICERID TRANSFER PROTEIN

Legal Events

Date Code Title Description
FC Refusal